middle.news
How Osteopore’s AUD 0.5m Bet on OsteoRx Could Transform Regenerative Medicine
8:36am on Monday 1st of September, 2025 AEST
•
Healthcare
Read Story
How Osteopore’s AUD 0.5m Bet on OsteoRx Could Transform Regenerative Medicine
8:36am on Monday 1st of September, 2025 AEST
Key Points
Osteopore invests AUD 0.5m to launch OsteoRx SPV
Controlling stake in RxCell Inc to be injected into OsteoRx
Collaboration with renowned scientists Dr Xianmin Zeng and Dr Brian Kennedy
Expansion into USD 19.34b stem cell and scaffold-based cell therapy markets
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Osteopore (ASX:OSX)
OPEN ARTICLE